Delivery Order SPE2D021DA002-SPE2D325F282D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,813.04 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Twinrix vaccine syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location with an ultimate completion date of September 8, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for $1,636.62 on April 23, 2025, with a completion date of April 24, 2025. The award covers the supply of Twinrix vaccine syringes under a firm fixed-price delivery order structure. This award was issued without a set-aside designation and represents a draw-down from DMS Pharmaceutical Group's larger indefinite delivery contract vehicle with the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $95,392.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a completion date of June 14, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,091.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,513.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Twinrix vaccine syringes. The contract carries a firm fixed-price structure with an ultimate completion date of August 19, 2025, and was executed on August 18, 2025. No set-aside designation was applied to this award, allowing DMS Pharmaceutical Group to compete directly in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,454.93 on August 11, 2025, for the supply of Twinrix vaccine syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,602.92 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of TWINRIX VACCINE SYRINGE and does not have a set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $8,014.60. The award, which has no set-aside designation, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. It covers the supply of Twinrix vaccine syringes, with a period of performance through August 6, 2024. DMS Pharmaceutical Group holds a significant...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F282DDelivery Order
The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete as a woman-owned small business in the open federal marketplace. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award indefinite delivery contract with DLA valued at $499,999,999 through November 2026 under the SPE2DB program. This underlying vehicle enables the issuance of firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products, including prescription medications, biologics, vaccines, and medical consumables supporting military healthcare facilities worldwide. As a registered federal contractor since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the Defense Department's pharmaceutical supply chain, consistently delivering specialized medical products to military health facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/1/25 |